LONDONGlaxoSmithKline PLC has scored a minor victory in the battle to keep sales of its  billionayear asthma treatment Advair from being lost to generic competitors  The company has obtained a preliminary injunction to prevent Sandozthe genericdrug division of Novartis AGfrom selling its rival inhaler AirFluSal Forspiro in Germany because of its color The Cologne regional court made the ruling Sandoz
  